Brian David Archbold News Today

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) declared a quarterly dividend on Tuesday, January 2nd, Zacks reports. Stockholders of record on Thursday, February 29th will be paid a dividend of 0.16 per share by the medical instruments supplier on Friday, March 15th. This represents a $0.64 dividend on an annualized basis and a dividend […]

Kayne Anderson Rudnick Investment Management LLC cut its stake in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares during the […]

Kayne Anderson Rudnick Investment Management LLC trimmed its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares during the period. Kayne Anderson Rudnick Investment Management LLC’s holdings in Mesa Laboratories were […]

Kayne Anderson Rudnick Investment Management LLC cut its stake in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 1.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 144,110 shares of the medical instruments supplier’s stock after selling 2,430 shares […]

Daiwa Securities Group Inc. decreased its holdings in Mesa Laboratories, Inc. (NASDAQ:MLAB – Free Report) by 8.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,603 shares of the medical instruments supplier’s stock after selling 400 shares during the quarter. Daiwa Securities Group Inc. […]

Mesa Laboratories (NASDAQ:MLAB – Get Free Report) was upgraded by equities research analysts at Evercore ISI from an “in-line” rating to an “outperform” rating in a research report issued on Thursday, Briefing.com reports. The brokerage currently has a $125.00 price target on the medical instruments supplier’s stock, up from their previous price target of $100.00. […]

Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Free Report) SVP Brian David Archbold sold 1,500 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $112.36, for a total value of $168,540.00. Following the completion of the sale, the senior vice president now […]